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Adaptations of the maternal immune response are necessary for pregnancy success.
Insufficient immune adaption is associated with pregnancy pathologies such as
infertility, recurrent miscarriage, fetal growth restriction, spontaneous preterm birth, and
preeclampsia. The maternal immune system is continuously exposed to paternal-fetal
antigens; through semen exposure from before pregnancy, through fetal cell exposure in
pregnancy, and through microchimerism after pregnancy. This results in the generation
of paternal-fetal antigen specific memory T cells. Memory T cells have the ability to
remember previously encountered antigens to elicit a quicker, more substantial and
focused immune response upon antigen reencounter. Such fetal antigen specific memory
T cells could be unfavorable in pregnancy as they could potentially drive fetal rejection.
However, knowledge on memory T cells in pregnancy has shown that these cells might
play a favorable role in fetal-maternal tolerance rather than rejection of the fetus. In recent
years, various aspects of immunologic memory in pregnancy have been elucidated and
the relevance and working mechanisms of paternal-fetal antigen specific memory T cells
in pregnancy have been evaluated. The data indicate that a delicate balance of memory
T cells seems necessary for reproductive success and that immunologic memory in
reproduction might not be harmful for pregnancy. This review provides an overview of the
different memory T cell subtypes and their function in the physiology and in complications
of pregnancy. Current findings in the field and possible therapeutic targets are discussed.
The findings of our review raise new research questions for further studies regarding the
role of memory T cells in immune-associated pregnancy complications. These studies
are needed for the identification of possible targets related to memory mechanisms for
studies on preventive therapies.
Keywords: pregnancy, reproduction, memory T cell, immunologic memory, literature review
INTRODUCTION
Immune tolerance toward paternal-fetal antigen is crucial for reproductive success since
dysfunctional tolerance is implicated in the pathophysiology of pregnancy complications as
infertility, recurrent miscarriage, fetal growth restriction, spontaneous preterm birth, and
preeclampsia (1–4). In reproduction, the maternal immune system is exposed to paternal-fetal
antigens (Figure 1). Firstly, the male antigen is introduced to the maternal immune system through
semen exposure even before pregnancy (5). Secondly, paternal-fetal antigens are exposed at the
fetal-maternal interface in pregnancy since the maternal immune cells in blood are in direct contact
with fetal trophoblast cells in the placenta (6, 7). Additionally, in pregnancy, there is trafficking of
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FIGURE 1 | Hypothesis on generation of the memory T cell population in reproduction through paternal-fetal antigen exposure. Firstly, naive T cells are exposed to the
male antigen through antigens in seminal fluid. A subsequent encounter with the antigens occurs during pregnancy through exposure to fetal antigens on trophoblast
cells and through microchimerism. Postpartum, the maternal immune system remains exposed to fetal antigens through microchimerism. In addition, postpartum,
memory T cells are possibly exposed to paternal antigens through exposure to seminal fluid. In a subsequent pregnancy, the maternal memory T cells likely
reaccumulate and respond to the cognate paternal-fetal antigens.
fetal cells expressing paternal-fetal antigens to maternal tissues
at low levels which can recirculate in the maternal blood
for years after pregnancy (8, 9). This phenomenon is called
microchimerism (8, 9). It has been shown that the exposure
of the maternal immune system to paternal-fetal antigens
induces a memory T cell population with paternal-fetal antigen
specificity (10–12).
The memory lymphocyte population is comprised of memory
T lymphocytes (T cells) and memory B lymphocytes (B cells)
(13, 14). Memory T cells are the most studied and appear to
be the most important memory cell population in reproduction.
Memory cells enable the immune system to protect the body from
pathogens efficiently by generating a more adequate immune
response to a known antigen, making it unnecessary to elicit a
new response to an antigen that was encountered before (15).
This process forms the basis for vaccination which is widely used
to prevent infectious diseases and more recently to fight cancer
and auto-immune diseases (16–18). In general, a more aggressive
immune response toward pathogens is protective for health since
the pathogen is cleared faster, however, the same aggressive
response toward paternal- or fetal antigens would be disastrous
for fetal and maternal health. Indeed, most studies of memory
T cell populations in reproduction indicated that memory T cell
subsets may exhibit a different function, proliferation pattern
and migratory abilities toward paternal antigens in healthy
pregnancies as compared with their function, proliferation and
migratory abilities toward other antigens (12, 19, 20). In fact,
specific memory cell populations have been shown to be involved
in generating immune tolerance, rather than immune rejection,
toward paternal-fetal antigens (12, 21–23).
In recent years, the implication and relevance of memory T
cells in pregnancy and complications of pregnancy have been
revealed. Major conceptual breakthroughs were seen in the T
cell field, showing the role of memory T cells in reproductive
fitness in mouse studies (11, 12, 21). Since increasing numbers
of human studies on memory T cells have been published, this
review gives an overview of the current literature on the different
memory T cell subtypes and their adaptation in pregnancy and
the implication of memory T cells in different complications of
pregnancy. We will mainly focus on human studies and refer to
mouse studies if needed. Current research gaps, controversies,
and possible therapeutic targets will also be discussed.
MEMORY T CELLS
The memory T cell population is formed during a primary
antigen response (24). In the primary response, antigens are
presented to T cells through major histocompatibility complex
(MHC) molecules (25). Depending on the type of MHC
molecule, either type I or type II, CD8 positive or CD4 positive T
cells respectively are activated through the T cell receptor (TCR)
on the cell membrane (25). Additional co-stimulatory molecules
can connect to co-stimulatory receptors on the T cell such as
CD28 and CD70, for extra induction of the T cell response
(25, 26). Depending on the cytokine environment, CD4+ cells
differentiate into either different T helper (Th) subsets (Th1, Th2,
and Th17) which help in inducing/activating immune responses
through secretion of cytokines, or into T regulatory (Treg)
cells which exert regulatory effects on other immune cells after
activation (27). After the primary response, most CD4+ cells die,
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but some CD4+ cells differentiate into CD4+memory T cells (24,
28). CD8+ cells also differentiate into different subpopulations;
i.e., effector CD8+ cells which are ready to release cytotoxic
cytokines or induce apoptosis via cell surface interaction, and
a small population of regulatory CD8+ cells which exhibit an
immune regulatory function (29). Once the pathogen is cleared,
most CD8+ cells die, however some proliferate into memory
CD8+ cells (29).
Several memory T cell subsets are known, and can be
distinguished by variousmarkers (Tables 1, 2). Themainmarkers
are CD45RO expression, and lack of CD45RA expression
(52, 53). The CD45RO+CD45RA− phenotype has been linked
to long living memory T cells (52, 53). It should be noted that
CD45RO expression and lack of CD45RA expression are not
conclusive markers for memory T cells, since their expression
does not predict long time survival and rapid effector function
upon secondary exposure per se (54). In addition, it has been
shown that CD45RO+ T cells can be reprogrammed and go
back to a CD45RO− naive phenotype (55, 56). So far there
are no other reliable markers of phenotype memory T cells in
clinical experiments, therefore, phenotypic characterization of
the memory cell population by CD45RO expression is widely
used. Memory CD4+ and CD8+ cells can be divided into subsets
based on their migration pattern, cytokine secretion abilities,
and protein expression profile. The main memory cell subsets
are the central memory (CM) cells and the effector memory
(EM) cells, although the number of subsets is expanding rapidly
(Tables 1, 2). The CM cell subset differentiates into effector
cells upon secondary antigen exposure and is characterized
by CCR7 expression which makes them home to secondary
lymphoid organs (53, 57). The EM cell subset is characterized by
their presence in peripheral tissue and direct pro-inflammatory
effector function upon secondary antigen encounter with the
cognate antigen (53). Below, an overview of the current
knowledge of the various memory T cell subsets in pregnancy
is reviewed (Supplementary Material).
CD4+ MEMORY CELLS IN PREGNANCY
Within the CD4+ memory cell population, a subdivision has
been made based on migration pattern and effector function;
i.e., CD4+ effector memory (CD4+ EM) cells, CD4+ central
memory (CD4+ CM) cells, CD4+ tissue resident memory (CD4+
TRM) cells, CD4+ T follicular helper memory (CD4+ FHM)
cells, CD4+ regulatory memory cells, and CD4+ memory stem
cells (58–65).
It has been known for many years that pregnancy and some
pregnancy complications affect the general CD4+ memory T cell
population. In 1996, it was shown that general CD4+memory cell
(CD4+CD45RO+) proportions in peripheral blood were lower
from the second trimester onwards until 2–7 days postpartum
compared to proportions in non-pregnant controls (66). These
findings have been followed up by studies in preeclampsia
(67–69), gestational diabetes (70), and preterm labor (71) in
which higher proportions of total memory T cells in peripheral
blood have been found compared to healthy pregnant controls.
Early studies also showed CD4+CD45RO+ memory cells in
the decidua and showed that CD45RO expression on CD4+
cells is upregulated in the decidua compared to CD4+ cells in
peripheral blood (72, 73). Later, Gomez-Lopez et al. suggested
a role for CD4+ memory cells in human term parturition by
showing an increase of CD4+ memory cells (CD4+CD45RO+)
using immunohistochemistry on choriodecidual tissue from
women in spontaneous labor at term compared to women with
term scheduled cesarean sections (74). The early data already
indicated that memory T cells are affected by pregnancy and
its complications. In more recent years, studies have focused on
specific subsets of CD4+ memory cells. These data are reviewed
per memory T cell subset below.
CD4+ Effector Memory Cells in Pregnancy
Th1, Th2, and possibly Th17 effector cells can differentiate into
CD4+ EM cells (75–77). CD4+ EM cell characterization is based
on the lack of expression of lymph node homing receptors CC-
chemokine receptor-7 (CCR7) and CD62L (L-selectin), which
enables them to migrate to peripheral tissue (59). EM cells
are the memory cells with the fastest immune response on a
secondary encounter. Within several hours after re-stimulation
with a memorized antigen, CD4+ EM cells produce a variety
of cytokines as interferon-gamma (IFN-gamma), tumor necrosis
factor (TNF), interleukin-4 (IL4), and IL5 (53, 77, 78). A specific
subtype of CD4+ EM cell can re-express CD45RA after antigen
stimulation (TEMRA) (79). These cells are poorly studied and
there are no published investigations on CD4+ TEMRA cells in
reproduction to our knowledge.
In the second and third trimesters of pregnancy, two
studies showed higher CD4+ EM cell (CD45RA−CCR7− and
CD45RO+CCR7−) proportions in peripheral blood, compared
to proportions of these cells in non-pregnant women (23, 30),
while another study found decreased numbers of CD4+ EM
cells in peripheral blood during pregnancy (34). Differences
between the studies could be due to the fact that that hormonal
fluctuations during the menstrual cycle were not taken into
account in the latter study. Not only is the proportion of
CD4+ EM cells increased during pregnancy, these cells also
showed increased expression of CD69 (30), as well as decreased
expression of programmed death-1 (PD-1) (23). This suggests
that there is increased activation of CD4+ EM cells, and that these
cells are less susceptible to apoptosis. The increase of CD4+ EM
cells is not only seen during pregnancy, but also years after when
CD4+ EM cell proportions remained increased, i.e., at gestation
levels as compared with women that have never been pregnant
(30). These cells also showed increased CD69 expression after
pregnancy, which could suggest persistent activation through
exposure to antigen. This could be related to microchimerism,
although it remains to be investigated whether the increased
EM cell proportion is due to an increase in cells specific for
paternal-fetal antigens.
Whereas, in blood the proportion of CD4+ EM cells of
the total CD4+ cell population was about 20–30% (19, 30, 31),
locally, in the decidua, the proportion of CD4+ EM cells
(CD45RA−CCR7−) was higher with 50–60% of the total CD4+
cell population being EM cells (19, 31). This may indicate
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accumulation of CD4+ EM cells in the decidua, although it can
also be simply due to the fact that naive T cells do not accumulate
in peripheral tissue (80). Important for the function of memory
T cells is the expression of co-stimulatory molecules like CD28
(81). Such molecules are important for the recall response of
memory T cells (82). Interestingly, within the CD4+ EM cell
population in the decidua, the proportion of the EM subset
not expressing co-stimulatory molecules is highly increased
compared to peripheral blood (19), suggesting that the CD4+
EM cells in the decidua may not be able to mount a secondary
response comparable to CD4+ EM cells in peripheral blood.
Despite this, increased IFN-gamma and IL4 expressions were
found in decidual CD4+ EM cells compared to CD4+ EM cells
in peripheral blood in vitro following mitogen stimulation (19).
This may be related to the high local progesterone concentrations
at the fetal maternal interface (19). The decidual EM cells
were not only able to respond to mitogen stimulation, they
were also able to respond to fetal antigens (19). The fact that
the decidual EM cells are able to respond to fetal antigens
and other stimuli suggests that there are extrinsic or intrinsic
mechanisms at the fetal-maternal interface to suppress these
cells. One of these mechanisms could be the presence of Treg
cells (83, 84). Another mechanism may be the expression of
immune inhibitory checkpoint receptors on decidual CD4+ EM
cells (19). Activation of these receptors inhibit immune responses
to avoid autoimmunity and chronic inflammation (85). Increased
expression of the immune inhibitory checkpoint receptors PD-1,
T cell immunoglobulin and mucin domain 3 (Tim-3), cytotoxic
T lymphocyte antigen 4 (CTLA-4), and lymphocyte activation
gene 3 (LAG-3), on CD4+ EM cells in the decidua was found
as compared to peripheral blood (19). These findings are in line
withWang et al. who showed that the majority of CD4+ EM cells
(CD44+CD62L−) in first trimester decidual tissue from healthy
terminated human pregnancies, expressed Tim-3 and PD-1 (86).
A role for such immune inhibitory check point receptors in
pregnancy has been shown in mouse studies (86). Blocking the
Tim-3 and PD-1 pathway (not on CD4+ EM cells specifically)
in healthy pregnant mice showed that lower expression of Tim-
3 and PD-1 increased fetal resorption rates (86). These studies
propose a regulatory function for CD4+ EM cells locally that
could be favorable for fetal-maternal immune tolerance and
prevent pregnancy loss.
The current data on CD4+ EM cells in women with
uncomplicated pregnancy outcomes show that during pregnancy
CD4+ EM cells may accumulate in the decidua and remain
present at higher levels and higher activated proportions in
peripheral blood postpartum (30). In addition, the CD4+ EM
cell population in the decidua has a different phenotype with
increased IFN-gamma expression, however the CD4+ EM cell
population also has increased expression of immune inhibitory
proteins compared to peripheral blood (19). To understand the
relevance and function of CD4+ EM cells in fetal-maternal
tolerance and their role in the postpartum period, further
research should focus on their general and more specifically
on their antigen specific function, since none of the studies
has shown antigen specific tolerance induction by CD4+ EM
cells yet.
Unfortunately, until now, CD4+ EM cells have been hardly
studied in complications of pregnancy. CD4+ EM cells were
studied in preeclampsia by Loewendorf et al. who performed
flow cytometric analyses on peripheral blood and a swab from
the intrauterine cavity during cesarean sections (32). They did
not find differences in levels of CD4+ EM cells between healthy
and preeclamptic women in peripheral blood or in lymphocytes
isolated from the intra uterine swab (32). However, since the
specific tissue of origin of the cells from the swab cannot
be defined, caution should be taken when interpreting these
results. In non-pregnant women suffering recurrent spontaneous
miscarriages, higher proportions of EM cells were observed in
peripheral blood compared to non-pregnant fertile controls (33).
This study did not further specify the CD4+ or CD8+ status
or phenotype. With the proposed relevance of CD4+ EM cells
in fetal-maternal tolerance it would be of great value to gain
knowledge on CD4+ EM cells in complications of pregnancy.
CD4+ Central Memory Cells in Pregnancy
CD4+ CM cells circulate in the blood and are home to lymph
nodes through expression of lymph node homing receptors
CCR7 and CD62L (57–59). CD4+ CM cells secrete IL2 and only
very low levels of effector cell cytokines (28, 53). Upon secondary
antigen exposure, or spontaneously, in the presence or absence
of polarizing cytokines, CD4+ CM cells differentiate into Th1,
Th2, and CD4+ EM cells, and produce effector cytokines as IFN-
gamma and IL4 (53, 87–89). Furthermore, CM cells can quickly
cause expansion of the antigen specific T cell population (89).
During pregnancy, as for CD4+ EM cells, CD4+ CM cells
are studied mainly in the circulating blood and less at the
fetal-maternal interface. One study looked at CD4+ CM cells
(CD45RA−CCR7+) in decidual tissue at the end of pregnancy
and showed that proportions of CD4+ CM cells were higher
compared to peripheral blood from non-pregnant women (31).
Another study evaluated first trimester decidual tissue from
terminated healthy pregnancies, and showed that about 40%
of CD4+ CM cells (CD44+CD62L+) were Tim-3+ and PD-1+
(86). This appears to be a subset of CD4+ EM cells that have
a strong suppressive capacity on proliferation and preferentially
produce Th2 type cytokines (86). Since blocking of PD-1 and
Tim-3 in pregnancies in mice induced fetal loss (86), the Tim-
3+PD-1+ CD4+ EM cells may be important for maintaining
normal pregnancy.
A number of studies in pregnancy observed that the
proportions of CD4+ CM cells (CD45RA−CCR7+) in peripheral
blood are comparable between women in the second or third
trimester of pregnancy and in healthy non-pregnant women
(23, 30, 34). However, it seems that after pregnancy the CD4+ CM
cell proportions in peripheral blood are increased, since CD4+
CM cells were higher in women after pregnancy compared to
pregnant women and compared to women that have never been
pregnant (30). Whether the CD4+ CM cells are activated in the
circulation of pregnant women remains to be established, since
expression of the activation marker CD69 was higher during
pregnancy as compared with non-pregnant women (30), whereas
expression of the activation markers HLA-DR and CD38 was not
affected in the CD4+ CM cell population (CCR7+CD45RO+) in
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peripheral blood from 3rd trimester pregnant women compared
to non-pregnant women (34). This higher CD69+ proportion
of CD4+ CM cells in pregnancy remained high in women
after pregnancy compared to women who have never been
pregnant (30).
To date, CD4+ CM cells are investigated in two complications
of pregnancy, i.e., preeclampsia and miscarriages. In
preeclampsia, slightly, but significantly higher proportions
of CD4+ CM cells (CD45RO+CCR7+) were found in peripheral
blood from preeclamptic women compared to healthy pregnant
women (32). Proportions of CD4+ CM cells isolated from a
swab from the intrauterine cavity during a cesarean section
did not show differences between preeclamptic and healthy
pregnant women (32). This study also analyzed expression of co-
stimulatory molecules, CD28, CD27, and the survival receptor
CD127 (IL7 receptor alpha chain), on CD4+ CM cells (32). Only
a difference in CD28 expression was found: in an intrauterine
swab from preeclamptic women, CD4+ CM cells expressed
lower levels of CD28 compared to healthy pregnant women
(32). In peripheral blood this difference was not observed (32).
In women suffering from recurrent spontaneous miscarriages,
higher levels of CM cells (CD45RO+CD62L+) have been found
in peripheral blood compared to fertile women (33). It was not
specified whether these CM cells were from the CD4+ or the
CD8+ lineage. Part of this increase is likely due to CD4+ CM
cells, since another study reported higher levels of CD4+ CM
cells (CD4+CD45RA−CCR7+) in peripheral blood from women
suffering from recurrent miscarriages compared to women with
proven fertility and women with no previous pregnancies (35).
As indicated above, Tim-3 and PD-1 expression on memory
cells may be important for a healthy pregnancy. This suggestion
is in line with the finding of decreased proportions of Tim-3+PD-
1+ CD4+ cells in decidua from patients who had undergone
miscarriage (86). Unfortunately, these CD4+ cells were not
stained for memory cell markers. Further studies on CD4+
CM cells in pregnancy complications in blood and at the fetal-
maternal interface are needed in order to be able to show that
these cells may play a role in the physiology of pregnancy and the
pathophysiology of complications.
CD4+ Regulatory Memory Cells in
Pregnancy
Treg cells have potent immunosuppressive properties. They
produce IL10 and transforming growth factor beta (TGFB),
and have the capability of suppressing CD4+, CD8+, and B
cell proliferation and cytokine secretion as well as inhibiting
effects on dendritic cells and macrophages (90–93). It was long
assumed that Treg cells did not survive the contraction phase
of the immune response and undergo apoptotic cell death (64).
Nevertheless, a long time surviving memory Treg cell subset has
now been shown to persist after antigen exposure (12, 64, 94, 95).
There is increasing evidence that memory Treg cells regulate
the EM immune response on a secondary encounter with a
memorized antigen (64). Treg memory function is implicated in
many different pathological and physiological contexts such as
auto-immune diseases (96), respiratory disorders (97), hepatitis
(98), and pregnancy (12). Treg memory cells are complex
to study, since no conclusive markers for a long-living Treg
cell population are known (64). Identification of the Treg
memory cell pool is therefore performed by combining Treg
cell markers as [forkhead box p3 (Foxp3+), CD25+, and
CD127− (99)] with memory cell markers [as CD45RO+ and
CD45RA− (52, 53)] (64).
In rodent models, Treg cells with fetal antigen specificity
and a memory phenotype have been shown to accumulate
in gestation and impact reproductive success in subsequent
pregnancies (12, 39, 40). Rowe et al. developed a mouse model
that demonstrated an increase of fetal antigen specific Treg
memory cells at mid-gestation in first pregnancies that remained
present at lower levels postpartum (12). The Treg memory cell
population expanded substantially with accelerated kinetics in a
following pregnancy as compared with the first pregnancy (12).
This expansion resulted in decreased resorption rates compared
to Treg memory cell ablated mice (12). The fetal antigen specific
memory Treg cells, as shown by Rowe et al. seem important
at mid gestation and it is hypothesized that they might be
especially valuable in subsequent pregnancies to set boundaries
for a secondary EM cell response toward paternal-fetal antigens
(12). Chen et al. showed that in early gestation in mice (during
implantation) self-antigen specific memory Treg cells and not
fetal antigen specific memory Treg cells are recruited to the
reproductive tract and create the tolerant environment for the
implantation of the blastocyst (39).
Similar to mouse studies, in early pregnancy fetal
maternal immune tolerance is probably not exclusively
managed by memory Treg cells, since higher naive Treg
cell subsets were associated with successful in vitro
fertilization (IVF)/intracytoplasmic sperm injection (ICSI)
treatment (37). Schlossberger et al. distinguished naive
Treg (CD45RA+CD25+Foxp3+) and memory Treg
(CD45RA−CD25+Foxp3+) subsets in blood samples from
women undergoing IVF/ICSI treatment and observed higher
proportions of naive Treg cells in women who became pregnant
compared to the women who did not (37). This finding could
indicate that in (preparation for) early pregnancy, higher levels
of naive Treg cells are important for successful pregnancy. It
could be speculated that these higher levels of naive Treg cells
might be able to proliferate into antigen experienced memory
Treg cells which are possibly beneficial in late pregnancy. This
hypothesis needs to be tested in further studies, but would be in
line with findings in mouse studies, in which the paternal antigen
specific Treg memory cells were important at mid gestation (12).
The same group followed up on this study and showed that
in healthy pregnant women, in early pregnancy (1st trimester)
the decrease in naive Treg cells is most likely due to a decreased
output of thymic Treg cells, since a decrease in recent thymic
emigrant Treg cells was found in early pregnancy (38). They also
showed that the increase in memory Treg cells in early pregnancy
seems to be due to a differentiation of the recent thymic emigrant
Treg cells, since an increased proportion of CD45RA−CD31−
memory Treg cells was found (38), which returned to normal
non-pregnancy levels over the course of pregnancy (38). In line
with their previous publication (37), this group showed again
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that the suppressive capacity of the naive Treg cells is increased
during pregnancy and the suppressive capacity of the memory
Treg cell population is decreased during pregnancy (38). At
the end of pregnancy, the proportion of CD4+ Treg memory
cells (CD45RA−Foxp3+) in peripheral blood were present at
comparable levels as in non-pregnant women (34, 38), which
may suggest that memory Treg cells either undergo apoptotic
cell death or reside in tissues toward the end of pregnancy. Thus,
CD4+ memory Treg cells are found to be favorable for pregnancy
in mice, differentiate from recent thymic emigrant Treg cells
in early human pregnancy, and circulate in peripheral blood.
Studies on their presence and function at the fetal-maternal
interface during pregnancy and studies postpartum and during
a second pregnancy are lacking.
Foxp3+ Treg cells are implicated in the pathophysiology of
many complications of pregnancy as, preeclampsia (4, 100),
recurrent miscarriage (101), and infertility (4, 102), however
the potential role of the memory cell subset of the Treg cell
population in different complications is not well studied. In
preeclampsia, there was a decrease of naive Treg cells and
an increase in memory Treg cells as compared with healthy
pregnancy (32, 103). Although the naive Treg population in
preeclampsia showed decreased suppressive activity compared
with healthy pregnancy, this was not the case for the memory cell
population (103). Further studies are needed to evaluate the role
of the memory Treg population in preeclampsia.
In women with gestational diabetes, phenotypic
characterization of memory Treg cell subsets showed
that the proportion of naive Treg cells (CD45RA+HLA-
DR−CD127+Foxp3+) was lower in women with gestational
diabetes compared to healthy pregnant women, independently
of whether diabetes was treated with a diet or insulin (41). The
proportion of memory Treg cells, on the other hand, increased
in gestational diabetes (41). Within the memory Treg cell
population HLA-DR+ and HLA-DR− memory Treg cells are
distinguished (104), in which HLA-DR+ memory Treg cells
have a more differentiated phenotype, are more suppressive
and secrete lower amounts of pro-inflammatory cytokines as
compared with HLA-DR− memory Treg cells (104). Whereas,
HLA-DR− memory Treg cells were increased in gestational
diabetes with dietary adjustment, HLA-DR+ memory Treg cells
were strongly increased in gestational diabetes treated with
insulin therapy compared to healthy pregnant women (41).
Whether this is an effect of the insulin treatment or a reflection
of the pathophysiology of the disease is not known.
In summary, studies on memory Treg cells in complications
of pregnancy show that memory Treg cells might be beneficial
for reproductive success in subsequent pregnancies in mice (12),
however human studies are inconclusive so far. The fact that
some studies find higher memory Treg cell levels in pregnancy
complications such as preeclampsia and gestational diabetes (32,
41, 103), whereas others find that lower levels prior to embryo
transfer in IVF/ICSI treatment are associated with pregnancy
success (37), could indicate specific roles depending on the
phase of pregnancy. Identification of more conclusive markers
for memory Treg cell function and longevity is a priority to
fully elucidate the role of memory Treg cells in reproduction.
In addition, since previous studies were mostly performed in
peripheral blood, studies on memory Treg cells should also focus
on the fetal-maternal interface, as it is known that memory
T cells not only reside in peripheral tissues but also in the
decidua (48, 74).
CD4+ Follicular Helper Memory Cells
in Pregnancy
CD4+ follicular helper cells, which are located mainly in
lymphoid organs and in particular in the germinal centers of
lymphoid organs, also have a memory cell subset, called CD4+
FHM cells (63, 105). They are known to assist B cells in their
differentiation process and produce IL10 and IL21 (106). CD4+
FHM cells are recognized by CXCR5, CD62L, CCR7, and Folate
receptor 4 (FR4) (106). Contrary to the effector T follicular helper
subset, CD4+ FHM cells exhibit low B-cell lymphoma 6 (Bcl-6)
expression (63, 106, 107). Bcl-6 is a transcriptional suppressor of
GATA3, TBET, and RORGT, and is of major importance for T
follicular helper functioning and maintenance (63). Within the
CD4+ FHM cell population, different CD4+ FHM cell subsets
can be distinguished based on PD-1, CCR7, and inducible T cell
co-stimulator (ICOS) expression (63, 106, 107).
One mouse and one human study reported on CD4+ FHM
cells in pregnancy (42, 43). In mid gestation, in mice after
allogeneic mating, T follicular helper cells (CD4+CXCR5+PD-
1+/ICOS+) were shown to accumulate in the uterus and placenta
(42). These CD4+ T follicular helper cells could be CD4+
FHM cells, since they showed an activated memory (CD44+)
phenotype. This putative CD4+ FHM population increased
abundantly toward late gestation, but this study also showed that
programmed death ligand-1 (PDL-1) blockage induced abortion
and increased the putative CD4+ FHM cell accumulation even
further (42). The study does suggest that CD4+ FHM cells
may be implicated in fetal-maternal tolerance and that excessive
abundance might be associated with pregnancy loss (42).
In accordance with the suggestion that increased numbers of
CD4+ FHM cells may be implicated in pregnancy loss, a human
study in recurrent miscarriage found higher decidual CD4+
FHM cells (CXCR5+PD-1+CCR7− and CXCR5+PD-1+ICOS+)
in spontaneous miscarriage decidual tissue compared to tissue
from elective terminations in healthy women (43). In peripheral
blood, the proportions of CD4+ FHM cells (CXCR5+PD-
1+CCR7− and CXCR5+PD-1+ICOS+) did not differ between
the groups, implying a local response (43). In summary, the
current data that exist on CD4+ FHM cells in complications of
pregnancy may suggest that pregnancy loss is associated with
abundance of CD4+ FHM cells. Thorough research is necessary
to increase fundamental knowledge on the function of TFH
memory cells in normal and complicated pregnancies.
CD4+ Tissue Resident Memory Cells
in Pregnancy
In the classification of memory T cells, CD4+ TRM cells
are distinguished from circulating cells (108, 109). Since no
conclusive defining markers for the TRM cells from the CD4+
compartment are known, they are difficult to investigate (62, 108,
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109). Occasionally, the markers for CD8+ TRM cells are used to
study TRM cells in the CD4+ compartment, although it is unclear
whether this is correct (Table 2) (108, 109). To the best of our
knowledge, no literature on CD4+ TRM cells in reproduction is
published yet.
CD4+ Memory Stem Cells in Pregnancy
CD4+ memory stem cells are a rare kind of memory T cell that
cannot be classified according to the general differentiation of
naive and memory cells using the CD45 isoforms (65). Long
living cells with a naive phenotype (CD45RA+CCR7+CD27+),
but with antigen specificity and effector function, were shown in
human blood years after Epstein Barr Virus infection (110). The
so-called T memory stem cells exhibit almost all conventional
memory cell like properties as high CXCR3, CD95, and IL2
receptor beta expression (65, 111), however they lack CD45RO
expression and show similar recirculation patterns as naive T cells
(65). Studies have shown that CD4+ memory stem cells play a
role in auto-immune diseases, Human Immunodeficiency Virus
(HIV) and immune protection from a range of infections (65). To
our knowledge, CD4+ memory stem cells have not been studied
in reproduction yet.
CD8+ MEMORY CELLS IN PREGNANCY
Similar to CD4+ memory cells, CD8+ memory cell subsets
are distinguished according to their migration pattern, cytokine
secretion abilities, and protein expression (Table 2) (112–114).
CD8+ memory cells are divided in several subpopulations:
CD8+ effector memory cells (CD8+ EM), CD8+ central memory
cells (CD8+ CM), CD8+ tissue resident memory cells (CD8+
TRM), CD8+ follicular helper memory cells (CD8+ FHM), and
CD8+ memory stem cells (58–65, 115, 116). CD8+ memory
cells with regulatory properties are described, however there
is no consensus on existence of a CD8+ Treg memory subset
(45). Most CD8+ memory cells are generated from antigen
experienced effector cells over the course of an immune response
(113, 117, 118), however some CD8+ memory cells may arise
directly from naive T cells (119, 120). CD8+ memory cells
form the first line of defense in mucosal tissues and are able
to produce effector cytokines and granzymes, IFN-gamma and
perforin upon stimulation without the need for co-stimulatory
signals (53, 121).
It has been known for many years that CD8+memory cells are
present in the decidua during pregnancy (73). Higher CD45RO+
proportions of CD8+ cells were found in first trimester decidua
compared to peripheral blood at the same time of pregnancy
(72, 73). Furthermore, the proportion of CD8+ memory
(CD8+CD45RO+) cells in peripheral blood did not differ
between pregnant and non-pregnant women (30, 73). In a further
study, the CD8+ memory T cell population was found to be
influenced by seminal fluid (122). Using immunohistochemistry,
CD8+ memory cells (CD3+CD8+CD45RO+) were shown to
be increased in the stroma and epithelium of human cervix
biopsies taken 12 h after unprotected coitus compared to
biopsies after a period of abstinence and biopsies after coitus
with condom use (122). Although this shows that memory
CD8+ cells are generated as a response toward seminal
fluid, it is unknown whether these cells are specific to the
paternal antigen. Furthermore, their role in preparation for
pregnancy and fetal-maternal tolerance is not known. More
recent studies have focused on evaluating the different CD8+
memory cell subsets in reproduction. This is reviewed per
subset below.
CD8+ Effector Memory Cells in Pregnancy
CD8+ EM cells express CD45RO, but lack CCR7 expression
and are therefore bound to circulate in peripheral blood
and non-lymphoid tissue (28, 112). CD8+ EM cells rapidly
produce effector cytokines as IL4, IL5, and IFN-gamma upon
secondary encounter with the cognate antigen and therewith
generate immediate protection (24). The CD8+ EM cells
express co-stimulatory molecules CD27 and CD28, which are
gradually lost with differentiation of CD8+ EM cells (47).
Using these molecules, the CD8+ EM cell population can be
subdivided in 4 EM cell subtypes; i.e., EM1 (CD27+CD28+),
EM2 (CD27+CD28−), EM3 (CD27−CD28−), and EM4
(CD27−CD28+) (Table 2) (47), with EM-1 being the most
prominent in peripheral blood (about 70%) (47, 123). Next to a
different immune phenotype, these subsets may exert different
functions (47).
CD45RA expression on CD8+ T cells is widely known to be
lost on antigen exposure, however on one highly differentiated
subpopulation of CD8+ EM cells, CD45RA is again expressed
despite previous antigen exposure (47, 121). These CD8+
memory cells are terminally differentiated and called CD45RA
revertant effector memory cells (CD8+ TEMRA or sometimes
abbreviated EMRA) (47, 121). CD8+ TEMRA cells exhibit
great cytolytic activity, but lack expansion abilities and CCR7
expression, disabling them to migrate to secondary lymphoid
tissue (47, 121).
Increasing evidence shows that CD8+ EM cells are involved
in the establishment of functional immune tolerance toward
the fetus (20, 46, 124). In peripheral blood, the total CD8+
EM cell population was similar in healthy non-pregnant women
compared to healthy pregnant women in the 2nd and 3rd
trimesters (30, 34). Several studies showed an altered activation
marker profile on CD8+ EM cells in pregnancy. Higher
expression of CD38+ on CD8+ EM (CD45RO+CCR7−) and
CD8+ TEMRA (CCR7−CD45RA+) cells was found in peripheral
blood from pregnant women in the 3rd trimester compared
to non-pregnant women (34, 44). Moreover, higher HLA-DR
expression, but comparable CD69 expression, were found on
CD8+ EM cells (CD45RO+CCR7−) in peripheral blood in
pregnant women compared to non-pregnant women (30, 34).
Interestingly, although during pregnancy the proportions of
CD8+ EM cells in blood were not different from the proportion
in non-pregnant women, higher proportions of CD8+ EM cells
(CD45RO+CCR7−) were found in peripheral blood fromwomen
postpartum compared to women who have never been pregnant
(30). The higher expression of some of the activation markers
on CD8+ EM cells in pregnancy suggest that CD8+ EM cells are
activated in peripheral blood in pregnancy. A similar expression
of inhibitory molecules PD-1 and PDL-1 on CD8+ EM cells
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was found, suggesting that their effector function remains the
same (23).
Approximately half of the CD8+ cells in the decidua were
found to be CD8+ EM cells (CD45RA−CCR7−), which is
about two-fold higher than the proportion of these cells in
peripheral blood (19, 22, 31). This may be due to preferential
accumulation of these cells in the decidua, but as for naive
CD4+ cells, it may also be due to the fact that naive
CD8+ cells do not accumulate in peripheral tissues (80). Not
only does the proportion of CD8+ EM cells differ between
peripheral blood and the decidua, also substantial differences
in phenotype, gene expression and function between these
cells in peripheral blood and decidua have been observed
(19, 22, 31, 46). CD8+ EM cells (CD45RA−CCR7−) in the
decidua have shown increased IFN-gamma and IL4 secretion
abilities and reduced perforin and granzyme B expression
compared to CD8+ EM cells in peripheral blood (19, 22).
Whether these specific functionalities of the decidual CD8+ EM
cells contribute to fetal-maternal immune tolerance remains to
be established.
More evidence for altered functionality of CD8+ EM cells
in the decidua compared to peripheral blood was found by
a study showing elevated expression of inhibitory check point
receptors PD-1, Tim-3, CTLA-4, and LAG-3 on decidual CD8+
EM cells compared to CD8+ EM cells in peripheral blood
(19, 45, 46). The higher Tim-3 and PD-1 expression on
decidual CD8+ T cells might be the result of interaction with
trophoblasts, since co-culturing CD8+ T cells with trophoblasts
induced upregulation of Tim-3 and PD-1 (45), suggesting
that trophoblasts may induce a function change, i.e., tolerance
in CD8+ EM cells in the decidua. In accordance with the
increased expression of activation markers, inhibitory check
point receptors, and cytokine production in decidual CD8+ EM
cells is the elevated gene-expression of several genes that was
found in decidual CD8+ EM cells compared to CD8+ EM cells
in peripheral blood (19, 46). Genes involved in chemotaxis,
inhibitory receptors, T cell activation, Treg cell differentiation
and genes associated with the IFN-gamma pathway were found
higher in decidual CD8+ EM cells compared to peripheral
blood CD8+ EM cells (19, 46). The different characteristics
of decidual CD8+ EM cells vs. peripheral blood CD8+ EM
cells might be beneficial for immune tolerance at the fetal
maternal interface.
The question arises whether the changes in CD8+ EM cells
are due to the appearance of fetal specific CD8+ EM cells.
H HY tetramers are used to detect maternal T cells with
specificity for Y-chromosome encoded HY-protein expressed by
a male fetus (125). The proportion of HY-specific CD8+ cells
(not further specified which memory subtype) in peripheral
blood in early pregnancy was 0.035% of the CD8+ population,
which almost tripled toward the end of pregnancy (10). The
majority of the HY-specific CD8+ memory cell population
in peripheral blood and decidua showed an effector memory
phenotype, being either CD8+ EM (CCR7−CD45RA−) or CD8+
TEMRA (CD45RA+CCR7−) (10, 125). Upon stimulation with
male cells, the HY-specific T cells were cytotoxic and secreted
IFN-gamma (10). The HY specific CD8+ cells in the decidua
expressed higher PD-1 and CD69 as compared with peripheral
blood (19).
In preeclampsia, CD8+ EM cell proportions and their
CD27 and CD28 expression were comparable to CD8+ EM
cell proportions in healthy women in peripheral blood and
in a swab from the intrauterine cavity (32). Contrary to
preeclampsia, in non-pregnant women following recurrent
spontaneous miscarriages, higher proportions of EM cells (not
specified whether from the CD4+ or CD8+ cell compartment)
were observed in peripheral blood compared to fertile non-
pregnant controls (33). Lissauer et al. found that CD8+
EM cell subsets are present at different proportions in
pregnancy in women with latent CMV infection (44). They
found that in CMV seropositive women the proportion of
CD8+ TEMRA cells (CD45RA+CCR7−) was higher and
that the CD8+ EM cell population was more differentiated
with higher EM3 (CD28−CD27−) and EM4 CD28+CD27−)
phenotypes and lower EM1 (CD28+CD27+) compared
to CMV seronegative pregnant women (44). With the
proposed important role for CD8+ EM cells in successful
pregnancies, it is worthwhile to investigate CD8+ EM cells
and their function in peripheral blood and in the decidua
in complications of pregnancy to further evaluate their role
in reproduction.
CD8+ Central Memory Cells in Pregnancy
CD8+ CM cells have little effector function and need to be
converted to other cell types before effector functions can be
induced (53, 112). In contrast to CD8+ EM cells, they are
highly proliferative upon stimulation and express the lymph node
homing receptor CCR7, which allows these cells to migrate to
secondary lymphoid tissue (57). CD8+ CM cells have the ability
to generate a diverse progeny, with different types of daughter
cells like CD8+ EM cells and effector cells (126). The main
cytokine produced by CD8+ CM cells is IL2, but they also
produce low levels of IFN-gamma and TNF (112).
In reproduction, CD8+ CM cells are less well studied than
CD8+ EM cells, this could be explained by their low prevalence,
as the proportions of CD8+ cells with a CM phenotype in
the decidua and peripheral blood are low (about 5% of CD8+
cells) (22, 30, 31). Three studies showed that CD8+ CM cell
proportions in peripheral blood are not altered by pregnancy
(23, 30, 34). CD38, CD28, and CD27 expression on the CD8+
CM cell population was also found to be similar in peripheral
blood in pregnant and non-pregnant women (23), although
HLA-DR expression on CD8+ CM cells was found higher in
peripheral blood from women in the third trimester compared
to non-pregnant women (34). Investigation of male-fetus specific
CD8+ CMcells in peripheral blood usingHY-dextramer staining,
revealed that very low proportions of HY specific CD8+ cells
have a CD8+ CM phenotype (10, 19). This could suggest that
fetal antigens do not reach the secondary lymphoid tissue, less
HY-specific CD8+ CM cells develop, and less HY-specific CD8+
CM cells recirculate into peripheral blood (10). Whether less
HY-specific CD8+ cells develop is not known.
Whether CD8+ CM cells are present at different proportions
in decidual tissue compared to peripheral blood remains
Frontiers in Immunology | www.frontiersin.org 11 April 2019 | Volume 10 | Article 625
Kieffer et al. Memory T Cells in Pregnancy
to be established, since one study did not find differences,
while another study found significantly lower CD8+ CM cell
(CD45RA−CCR7+) proportions in decidual tissue compared
to peripheral blood (22, 31). A possible explanation for the
discrepancy could be methodological, as only one of the studies
used a viability stain. Granzyme B and perforin are very low
expressed by CD8+ CM cells and no differences have been
found for granzyme B and perforin expression when comparing
decidual and peripheral blood CD8+ CM cells (22).
In preeclampsia, CD8+ CM cell proportions and their CD28
and CD27 expression were comparable to the proportions in
healthy women, both in peripheral blood and in a swab from the
intrauterine cavity (32). In peripheral blood from non-pregnant
women suffering from recurrent spontaneousmiscarriage, higher
proportions of CD8+ CM cells (CD45RO+CD62L+) were found
compared to non-pregnant fertile women (33). However, as
CD4+ or CD8+ cell phenotype was not identified, it is not sure if
this finding reflects a difference in CD8+ CM cells.
CD8+ Tissue Resident Memory T Cells
in Pregnancy
Tissue resident memory (TRM) cells are a distinct subpopulation
of CD8+ memory cells which reside in peripheral tissues,
including endometrium and decidua (49, 51). After the primary
immune response, CD8+ TRM cells reside in peripheral
tissues awaiting a secondary encounter without recirculating in
peripheral blood or lymph nodes (127–129). Upon reactivation,
CD8+ TRM cells produce IFN-gamma, granzyme B, and
perforins (127). TRM cells are typically identified by the
expression of different surface markers as CD103, CD69, and
CD49A (127, 130–133). CD8+ TRM cells are found in the
entire reproductive tract and in contrast to CD8+ TRM cells
in the kidney, skin and salivary gland, do not require IL15 for
maintenance of the cell population (48, 49, 134).
Next to this, CD8+ TRM cells in the reproductive tract seem to
be able to recruit circulating memory T cells, independently from
their cognate antigen, into mucosal tissue of the reproductive
tract and convert them to TRM cells (50). These data are
suggestive of a well-functioning first line of defense of memory
T cells in the reproductive tract. Presumably, TRM cells, CD4+
or CD8+, are the first memory T cells the male antigens
on spermatozoa will encounter. Despite their presence in the
reproductive tract, little information is available on their function
and presence during pregnancy. One study looked at CD8+
TRM in endometrial tissue and showed the presence of high
proportions of memory CD8+ cells in endometrial tissue, which
was similar in women with recurrent miscarriages and control
women (51). Part of these CD8+ memory T cells expressed
CD103, indicating that the cells may be CD8+ TRM cells
(51). The proportion of CD8+ memory cells expressing CD103
was similar in women with recurrent miscarriages and control
women (51). However, the percentage of CD8+ memory cells
expressing CD69, a TRM marker, was decreased in women with
recurrent miscarriages as compared with control women (51).
This might suggest a decrease in CD8+ TRM cells in women with
recurrent miscarriage.
CD8+ Regulatory Memory, CD8+ Follicular
Helper Memory, and CD8+ Memory Stem
Cells in Pregnancy
The regulatory memory, follicular helper memory, and the
memory stem cell subsets are relatively well studied in the CD4+
cell compartment but only to a limited extent in the CD8+
cell compartment. CD8+ cells with immune regulatory abilities
are described in literature (135–137), however, the existence of
a memory cell subset within the CD8+ Treg cell population
is still uncertain (45). CD8+ cells with expression of follicular
helper cell marker CXCR5, and memory cell marker CD45RO,
are identified in germinal centers of human tonsils, and were
found to support B cells (116, 138). The presence of such CD8+
follicular helper memory cells are only very recently confirmed
and are not studied in pregnancy yet (116). CD8+ memory stem
cells, as for their CD4+ counterpart, are antigen specific memory
cells with a naive phenotype and are mostly studied in oncology
settings (115, 139–141). Research on CD8+ regulatory memory,
CD8+ FHM, and CD8+ memory stem cells in pregnancy will be
of interest, but more knowledge on their functioning in general is
needed before studying their role in reproduction.
MEMORY T CELLS IN PREGNANCY AS
POSSIBLE THERAPEUTIC TARGETS
Literature shows that memory T cells are likely implicated in
fetal-maternal tolerance before, during and after pregnancy.
Firstly, it has been shown that exposure to seminal fluid before
pregnancy induces a memory T cell population in the ectocervix
(122). Even though there is no evidence yet that these memory
cells are paternal-antigen specific, this could be a mechanism
that contributes to tolerance toward paternal-fetal antigens. This
mechanism is supported by existing epidemiologic data showing
an association between a longer period of exposure to seminal
fluid of the future father and a lower risk of preeclampsia (142–
144). Generating paternal specificmemory T cells as a therapeutic
target, through paternal cell immunization before conception
seems obvious and has indeed been carried out by several studies
(145, 146). Studies are however small, but a meta-analysis of
7 small studies showed an improvement in clinical pregnancy
rate following IVF treatment when seminal plasma is used as
an adjunct treatment (average pregnancy rate increased from
25% in the control group to 29% in the seminal plasma treated
group), with no significant increases in live birth or ongoing
pregnancy rate (146). Since in these studies, timed intercourse
or deposition of untreated semen in the vagina before IVF was
used, it is not known whether the positive effect of semen is due
to the seminal plasma itself or to paternal-fetal antigen exposure.
This should be subject of future research. In order to potentially
achieve better results, additional options for priming may be
tested. An additional option could be a prime and pull method,
by first eliciting an immune response to recruit T cells into the
reproductive tract, followed by topical vaccination, a method that
has been shown to be effective in genital herpes prevention (147).
Secondly, this review indicates that tolerance mechanisms
involving memory T cells are in place during pregnancy. Various
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alterations in memory T cell function and levels have been
shown, which together likely ensure tolerance; for instance,
CD4+ Treg memory cells may play an important role, while also
low responsive PD-1+Tim-3+ CD8+ memory cells are present
at the fetal-maternal interface, which may also be important.
These different tolerating mechanisms and their interactions
should be further investigated, while it is also important to
focus on their alterations in complications of pregnancy. The
lack of knowledge on these mechanisms in healthy pregnancy
and how they are affected in complications of pregnancy, makes
therapeutic options using immunemodulation of memory T cells
to treat pregnancy complications not feasible yet.
Thirdly, after pregnancy, maternal immune cells are exposed
to fetal-paternal antigens through microchimerism and possibly
through semen exposure (8, 9). Since CD4+ memory T cells are
known to require low-levels of antigen exposure for long term
maintenance (60, 148, 149), it is proposed that microchimerism
and semen exposure are ways to ensure persistence of the
fetal-paternal specific CD4+ memory cell population (150–152).
Thorough investigations on possible beneficial effects of memory
T cells on reproductive success and of microchimerism on
memory T cell populations should point out whether this could
bring forward another possible therapeutic target. Lowering
pregnancy complication rates through priming and enhancing
the maternal memory T cell repertoire in parous women could
be considered for future therapies. These could involve similar
approaches as therapeutic options before pregnancy.
CONCLUSIONS
To conclude, a delicate balance of memory T cells seems
necessary for successful pregnancy and memory T cells might
not be harmful for pregnancy, but in fact, they may induce
tolerance. Memory T cells show different phenotypes, dynamics,
and functioning in uncomplicated pregnancies compared to
memory T cells outside the reproductive context. Together, these
mechanisms may induce tolerance toward fetal antigens during
pregnancy. More research on memory T cells in pregnancy
is needed to better understand the function of these cells in
pregnancy and to develop therapeutic strategies for pregnancy
complications based on memory T cells.
AUTHOR CONTRIBUTIONS
TK organized financial support, built the search strategy,
performed the literature study, and wrote the first draft of the
manuscript. AL organized financial support, built the search
strategy, performed the literature study, and reviewed and
edited the manuscript. SS, MF, and JP reviewed and edited
the manuscript, organized financial support, and supervised
the project.
FUNDING
This study was funded by the University Medical Center
Groningen, the University of Groningen, Junior Scientific
Masterclass MD/PhD grants (awarded to TK and AL) and a
Mandema Stipendium So: (awarded to JP).
SUPPLEMENTARY MATERIAL




1. Cudihy D, Lee R. The pathophysiology of pre-eclampsia:
current clinical concepts. J Obstet Gynaecol. (2009) 29:576–82.
doi: 10.1080/01443610903061751
2. Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights
into mechanisms behind miscarriage. BMC Med. (2013) 11:154.
doi: 10.1186/1741-7015-11-154
3. Zenclussen AC. Adaptive immune responses during pregnancy.Am J Reprod
Immunol. (2013) 69:291–303. doi: 10.1111/aji.12097; 10.1111/aji.12097
4. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance
in pregnancy: a new target for infertility treatment? Hum Reprod Update.
(2009) 15:517–35. doi: 10.1093/humupd/dmp004
5. Robertson SA, Guerin LR, Bromfield JJ, BransonKM, AhlströmAC, Care AS.
Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool
and induces tolerance to paternal alloantigens in mice. Biol Reprod. (2009)
80:1036–45. doi: 10.1095/biolreprod.108.074658
6. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, et al. Two-
way cell traffic between mother and fetus: biologic and clinical implications.
Blood. (1996) 88:4390–5.
7. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences
for maternal and offspring’s health. Nat Med. (2013) 99:548–56.
doi: 10.1038/nm.3160
8. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal
progenitor cells persist in maternal blood for as long as 27 years postpartum.
Proc Natl Acad Sci USA. (1996) 93:705–8. doi: 10.1073/pnas.93.2.705
9. Nelson JL. Your cells are my cells. Sci Am. (2008) 298:64–71.
doi: 10.1038/scientificamerican1208-64
10. Lissauer D, Piper K, Goodyear O, Kilby MD, Moss PAH. Fetal-specific
CD8+ cytotoxic T cell responses develop during normal human pregnancy
and exhibit broad functional capacity. J Immunol. (2012) 189:1072–80.
doi: 10.4049/jimmunol.1200544
11. Kahn DA, Baltimore D. Pregnancy induces a fetal antigen-specific maternal
T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci
USA. (2010) 107:9299–304. doi: 10.1073/pnas.1003909107
12. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory
memory that sustains anergy to fetal antigen. Nature. (2012) 490:102–6.
doi: 10.1038/nature11462
13. Wakim LM, Bevan MJ. From the thymus to longevity in the periphery. Curr
Opin Immunol. (2010) 22:274–8. doi: 10.1016/j.coi.2010.03.003
14. Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. (2015)
15:149–59. doi: 10.1038/nri3802
15. Ahmed R, Gray D. Immunological memory and protective immunity:
understanding their relation. Science. (1996) 272:54–60.
16. Sallusto F, Lanzavecchia A, Araki K, Ahmed R. From vaccines to memory
and back. Immunity. (2010) 33:451–63. doi: 10.1016/j.immuni.2010.10.008
17. Larché M, Wraith DC. Peptide-based therapeutic vaccines for allergic and
autoimmune diseases. Nat Med. (2005) 11:S69–76. doi: 10.1038/nm1226
18. Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nat
Rev Cancer. (2006) 6:204–16. doi: 10.1038/nrc1815
19. Powell RM, Lissauer D, Tamblyn J, Beggs A, Cox P, Moss P, et al. Decidual
T cells exhibit a highly differentiated phenotype and demonstrate potential
Frontiers in Immunology | www.frontiersin.org 13 April 2019 | Volume 10 | Article 625
Kieffer et al. Memory T Cells in Pregnancy
fetal specificity and a strong transcriptional response to IFN. J Immunol.
(2017) 199:3406–17. doi: 10.4049/jimmunol.1700114
20. Tilburgs T, Strominger JL. CD8+ Effector T cells at the fetal-maternal
interface, balancing fetal tolerance and antiviral immunity. Am J Reprod
Immunol. (2013) 69:395–407. doi: 10.1111/aji.12094
21. Barton BM, Xu R, Wherry EJ, Porrett PM. Pregnancy promotes
tolerance to future offspring by programming selective dysfunction
in long-lived maternal T cells. J Leukoc Biol. (2017) 101:975–87.
doi: 10.1189/jlb.1A0316-135R
22. Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings
GM, et al. Human decidual tissue contains differentiated CD8+ effector-
memory T cells with unique properties. J Immunol. (2010) 185:4470–7.
doi: 10.4049/jimmunol.0903597
23. Shah NM, Herasimtschuk AA, Boasso A, Benlahrech A, Fuchs D, Imami
N, et al. Changes in T cell and dendritic cell phenotype from mid to late
pregnancy are indicative of a shift from immune tolerance to immune
activation. Front Immunol. (2017) 8:1138. doi: 10.3389/fimmu.2017.01138
24. Lanzavecchia A, Sallusto F, Lanzavecchia Federica AS, Lanzavecchia
A, Sallusto F. Understanding the generation and function of
memory T cell subsets. Curr Opin Immunol. (2005) 17:326–32.
doi: 10.1016/j.coi.2005.04.010
25. Rudolph MG, Stanfield RL, Wilson IA. How TCRS bind MHCS,
peptides, and coreceptors. Annu Rev Immunol. (2006) 24:419–66.
doi: 10.1146/annurev.immunol.23.021704.115658
26. Sharpe AH. Mechanisms of costimulation. Immunol Rev. (2009) 229:5–11.
doi: 10.1111/j.1600-065X.2009.00784.x
27. Zhu J, Paul WE. CD4T cells: fates, functions, and faults. Blood. (2008)
112:1557–69. doi: 10.1182/blood-2008-05-078154
28. Mueller SN, Gebhardt T, Carbone FR, Heath WR. Memory T cell subsets,
migration patterns, and tissue residence. Annu Rev Immunol. (2013)
31:137–61. doi: 10.1146/annurev-immunol-032712-095954
29. Obar JJ, Lefrançois L. Memory CD8+ T cell differentiation. Ann N Y Acad
Sci. (2010) 1183:251–66. doi: 10.1111/j.1749-6632.2009.05126.x
30. Kieffer TEC, Faas MM, Scherjon SA, Prins JR. Pregnancy persistently
affects memory T cell populations. J Reprod Immunol. (2017) 119:1–8.
doi: 10.1016/j.jri.2016.11.004
31. Feyaerts D, Benner M, van Cranenbroek B, van der Heijden OWH, Joosten I,
van der Molen RG. Human uterine lymphocytes acquire a more experienced
and tolerogenic phenotype during pregnancy. Sci Rep. (2017) 7:2884.
doi: 10.1038/s41598-017-03191-0
32. Nguyen TA, Kahn DA, Loewendorf AI. Maternal—fetal rejection reactions
are unconstrained in preeclamptic women. PLoS ONE. (2017) 12:e0188250.
doi: 10.1371/journal.pone.0188250
33. Ramhorst R, Garcia V, Agriello E, Corigliano A, Etchepareborda E,
Irigoyen M, et al. Intracellular expression of CD69 in endometrial and
peripheral T cells represents a useful marker in women with recurrent
miscarriage: Modulation after allogeneic leukocyte immunotherapy. Am
J Reprod Immunol. (2003) 49:149–58. doi: 10.1034/j.1600-0897.2003.
00021.x
34. Loewendorf AI, Nguyen TA, Yesayan MN, Kahn DA. Normal human
pregnancy results in maternal immune activation in the periphery
and at the uteroplacental interface. PLoS ONE. (2014) 9:e96723.
doi: 10.1371/journal.pone.0096723
35. Carbone J, Sarmiento E, Gallego A, Lanio N, Navarro J, García S, et al.
Peripheral blood T- and B-cell immunophenotypic abnormalities in selected
women with unexplained recurrent miscarriage. J Reprod Immunol. (2016)
113:50–3. doi: 10.1016/j.jri.2015.11.003
36. Tilburgs T, Roelen D, van der Mast B, de Groot-Swings G, Kleijburg
C, Scherjon SA, et al. Evidence for a selective migration of fetus-
specific CD4+CD25bright regulatory T cells from the peripheral blood
to the decidua in human pregnancy. J Immunol. (2008) 180:5737–45.
doi: 10.4049/jimmunol.180.8.5737
37. Schlossberger V, Schober L, Rehnitz J, Schaier M, Zeier M, Meuer S, et al.
The success of assisted reproduction technologies in relation to composition
of the total regulatory T cell (Treg) pool and different Treg subsets. Hum
Reprod. (2013) 28:3062–73. doi: 10.1093/humrep/det316
38. Wagner MI, Mai C, Schmitt E, Mahnke K, Meuer S, Eckstein V,
et al. The role of recent thymic emigrant-regulatory T-cell (RTE-Treg)
differentiation during pregnancy. Immunol Cell Biol. (2015) 93:858–67.
doi: 10.1038/icb.2015.51
39. Chen T, Darrasse-Jeze G, Bergot A-S, Courau T, Churlaud G,
Valdivia K, et al. Self-specific memory regulatory T cells protect
embryos at implantation in mice. J Immunol. (2013) 191:2273–81.
doi: 10.1016/j.micinf.2011.07.011.Innate
40. Kalekar LA, Schmiel SE, Nandiwada SL, Lam WY, Barsness LO, Zhang N,
et al. CD4+ T cell anergy prevents autoimmunity and generates regulatory T
cell precursors. Nat Immunol. (2016) 17:304–14. doi: 10.1038/ni.3331
41. Schober L, Radnai D, Spratte J, Kisielewicz A, Schmitt E, Mahnke K, et al.
The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
Clin Exp Immunol. (2014) 177:76–85. doi: 10.1111/cei.12300
42. Zeng W, Liu Z, Zhang S, Ren J, Ma X, Qin C, et al. Characterization of T
follicular helper cells in allogeneic normal pregnancy and PDL1 blockage-
induced abortion. Sci Rep. (2016) 6:36560. doi: 10.1038/srep36560
43. Luan X, Kang X, Li W, Dong Q. An investigation of the relationship between
recurrent spontaneous abortion and memory T follicular helper cells. Am J
Reprod Immunol. (2017) 78:e12714. doi: 10.1111/aji.12714
44. Lissauer D, Choudhary M, Pachnio A, Goodyear O, Moss PAH, Kilby
MD. Cytomegalovirus sero positivity dramatically alters the maternal CD8T
cell repertoire and leads to the accumulation of highly differentiated
memory cells during human pregnancy. Hum Reprod. (2011) 26:3355–65.
doi: 10.1093/humrep/der327
45. Wang S, Li Y, Piao H, Hong X, Zhang D, Xu Y, et al. PD-1 and Tim-3
pathways are associated with regulatory CD8+ T-cell function in decidua
and maintenance of normal pregnancy. Cell Death Dis. (2015) 6:e1738.
doi: 10.1038/cddis.2015.112
46. van der Zwan A, Bi K, Norwitz ER, Crespo ÂC, Claas FHJ, Strominger JL,
et al. Mixed signature of activation and dysfunction allows human decidual
CD8+ T cells to provide both tolerance and immunity. Proc Natl Acad Sci
USA. (2018) 115:385–90. doi: 10.1073/pnas.1713957115
47. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM,
et al. Four functionally distinct populations of human effector-
memory CD8+ T lymphocytes. J Immunol. (2007) 178:4112–9.
doi: 10.4049/JIMMUNOL.178.7.4112
48. Schenkel JM,Masopust D. Tissue-residentmemory T cells. Immunity. (2014)
41:886–97. doi: 10.1016/j.immuni.2014.12.007
49. Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK,
et al. Antigen-independent differentiation and maintenance of effector-
like resident memory T cells in tissues. J Immunol. (2012) 188:4866–75.
doi: 10.4049/jimmunol.1200402
50. Beura LK, Mitchell JS, Thompson EA, Schenkel JM, Mohammed J,
Wijeyesinghe S, et al. Intravital mucosal imaging of CD8+ resident
memory T cells shows tissue-autonomous recall responses that
amplify secondary memory article. Nat Immunol. (2018) 19:173–82.
doi: 10.1038/s41590-017-0029-3
51. Southcombe JH, Mounce G, McGee K, Elghajiji A, Brosens J, Quenby S, et al.
An altered endometrial CD8 tissue resident memory T cell population in
recurrent miscarriage. Sci Rep. (2017) 7:41335. doi: 10.1038/srep41335
52. Michie CA, McLean A, Alcock C, Beverley PCL. Lifespan of human
lymphocyte subsets defined by CD45 isoforms. Nature. (1992) 360:264–5.
doi: 10.1038/360264a0
53. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory
T cell subsets: function, generation, and maintenance. Annu Rev Immunol.
(2004) 22:745–63. doi: 10.1146/annurev.immunol.22.012703.104702
54. Booth NJ, McQuaid AJ, Sobande T, Kissane S, Agius E, Jackson SE, et al.
Different proliferative potential and migratory characteristics of human
CD4+ regulatory T cells that express either CD45RA or CD45RO. J
Immunol. (2010) 184:4317–26. doi: 10.4049/jimmunol.0903781
55. Henson SM, Riddell NE, Akbar AN. Properties of end-stage human T cells
defined by CD45RA re-expression. Curr Opin Immunol. (2012) 24:476–81.
doi: 10.1016/j.coi.2012.04.001
56. Dunne PJ, Belaramani L, Fletcher JM, Fernandez de Mattos S, Lawrenz M,
Soares MVD, et al. Quiescence and functional reprogramming of Epstein-
Barr virus (EBV)-specific CD8+ T cells during persistent infection. Blood.
(2005) 106:558–65. doi: 10.1182/blood-2004-11-4469
57. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Müller I, Wolf E, et al.
CCR7 coordinates the primary immune response by establishing functional
Frontiers in Immunology | www.frontiersin.org 14 April 2019 | Volume 10 | Article 625
Kieffer et al. Memory T Cells in Pregnancy
microenvironments in secondary lymphoid organs. Cell. (1999) 99:23–33.
doi: 10.1016/S0092-8674(00)80059-8
58. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration
in secondary lymphoid organs. Annu Rev Immunol. (2005) 23:127–59.
doi: 10.1146/annurev.immunol.23.021704.115628
59. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the
generation of memory CD4T cells in the whole body. Nature. (2001)
410:101–5. doi: 10.1038/35065111
60. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+
effector and memory T cell generation. Nat Immunol. (2003) 4:835–42.
doi: 10.1038/ni969
61. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, et al.
Different patterns of peripheral migration by memory CD4+ and CD8+ T
cells. Nature. (2011) 477:216–9. doi: 10.1038/nature10339
62. Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N,
et al. Skin effector memory T cells do not recirculate and provide immune
protection in alemtuzumab-treated CTCL patients. Sci Transl Med. (2012)
4:117ra7. doi: 10.1126/scitranslmed.3003008
63. Hale JS, Ahmed R. Memory T follicular helper CD4T cells. Front Immunol.
(2015) 6:16. doi: 10.3389/fimmu.2015.00016
64. Rosenblum MD, Way SS, Abbas AK. Regulatory T cell memory. Nat. Rev.
Immunol. (2015) 1:1–12. doi: 10.1038/nri.2015.1
65. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human
memory T cell subset with stem cell–like properties. Nat Med. (2011)
17:1290–7. doi: 10.1038/nm.2446
66. Matthiesen L, Berg G, Ernerudh J, Håkansson L. Lymphocyte subsets and
mitogen stimulation of blood lymphocytes in normal pregnancy. Am J
Reprod Immunol. (1996) 35:70–9. doi: 10.1111/j.1600-0897.1996.tb00010.x
67. Chaiworapongsa T, Gervasi MT, Refuerzo J, Espinoza J, Yoshimatsu J,
Berman S, et al. Maternal lymphocyte subpopulations (CD45RA+ and
CD45RO+) in preeclampsia. Am J Obstet Gynecol. (2002) 187:889–93.
doi: 10.1067/mob.2002.127309
68. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz
B, Leszczynska-Gorzelak B, et al. Activated T lymphocytes
in pre-eclampsia. Am J Reprod Immunol. (2007) 58:39–45.
doi: 10.1111/j.1600-0897.2007.00489.x
69. Matthiesen L, Berg G, Ernerudh J, Skogh T. Lymphocyte subsets and
autoantibodies in pregnancies complicated by placental disorders. Am J
Reprod Immunol. (1995) 33:31–9. doi: 10.1111/j.1600-0897.1995.tb01135.x
70. Mahmoud FF, Haines DD, Abul HT, Omu AE, Abu-Donia MB.
Butyrylcholinesterase activity in gestational diabetes: correlation with
lymphocyte subpopulations in peripheral blood. Am J Reprod Immunol.
(2006) 56:185–92. doi: 10.1111/j.1600-0897.2006.00416.x
71. Oleszczuk J, Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J.
Alterations in the immune system of patients with imminent preterm labour.
Gynecol Obstet Invest. (2000) 49:110–3. doi: 10.1159/000010226
72. Slukvin II, Merkulova AA, Vodyanik MA, Chernyshov VP. Differential
expression of CD45RA and CD45RO molecules on human decidual and
peripheral blood lymphocytes at early stage of pregnancy. Am J Reprod
Immunol. (1996) 35:16–22.
73. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ito A, et al. A study
of CD45RO, CD45RA and CD29 antigen expression on human decidual
T cells in an early stage of pregnancy. Immunol Lett. (1994) 40:193–7.
doi: 10.1016/0165-2478(93)00019-A
74. Gomez-Lopez N, Vega-Sanchez R, Castillo-Castrejon M, Romero R,
Cubeiro-Arreola K, Vadillo-Ortega F. Evidence for a role for the adaptive
immune response in human term parturition. Am J Reprod Immunol. (2013)
69:212–30. doi: 10.1111/aji.12074
75. Pepper M, Linehan JL, Pagán AJ, Zell T, Dileepan T, Cleary PP, et al.
Different routes of bacterial infection induce long-lived TH1 memory cells
and short-lived TH17 cells. Nat Immunol. (2010) 11:83–9. doi: 10.1038/
ni.1826
76. Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. Memory
CD4T cells emerge from effector T-cell progenitors.Nature. (2008) 452:356–
60. doi: 10.1038/nature06672
77. Pepper M, Jenkins MK. Origins of CD4(+) effector and central memory T
cells. Nat Immunol. (2011) 12:467–71. doi: 10.1038/ni.2038
78. MacLeod MKL, Kappler JW, Marrack P. Memory CD4T cells:
generation, reactivation and re-assignment. Immunology. (2010) 130:10–5.
doi: 10.1111/j.1365-2567.2010.03260.x
79. Tian Y, Babor M, Lane J, Schulten V, Patil VS, Seumois G, et al.
Unique phenotypes and clonal expansions of human CD4 effector
memory T cells re-expressing CD45RA. Nat Commun. (2017) 8:1473.
doi: 10.1038/s41467-017-01728-5
80. Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol.
(2010) 11:21–7. doi: 10.1038/ni.1817
81. Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28
Costimulation: from mechanism to therapy. Immunity. (2016) 44:973–88.
doi: 10.1016/j.immuni.2016.04.020
82. Langenhorst D, Haack S, Göb S, Uri A, Lühder F, Vanhove B, et al. CD28
Costimulation of T helper 1 cells enhances cytokine release in vivo. Front
Immunol. (2018) 9:1060. doi: 10.3389/fimmu.2018.01060
83. Sasaki Y. Decidual and peripheral blood CD4+CD25+ regulatory T cells in
early pregnancy subjects and spontaneous abortion cases.Mol Hum Reprod.
(2004) 10:347–53. doi: 10.1093/molehr/gah044
84. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de
Groot-Swings GM, et al. Differential distribution of CD4+CD25bright
and CD8+CD28- T-cells in decidua and maternal blood during human
pregnancy. Placenta. (2006) 27:47–53. doi: 10.1016/j.placenta.2005.11.008
85. Dyck L, Mills KHG. Immune checkpoints and their inhibition in
cancer and infectious diseases. Eur J Immunol. (2017) 47:765–79.
doi: 10.1002/eji.201646875
86. Wang S, Zhu X, Xu Y, Zhang D, Li Y, Tao Y, et al. Programmed cell death-1
(PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells
to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.Hum
Reprod. (2016) 31:700–11. doi: 10.1093/humrep/dew019
87. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J.
Chemokine receptor expression identifies pre–T helper (Th)1, Pre–Th2, and
nonpolarized cells among human CD4 + central memory T cells. J Exp Med.
(2004) 200:725–35. doi: 10.1084/jem.20040774
88. Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate
long-term immunity to Leishmania major in the absence of persistent
parasites. Nat Med. (2004) 10:1104–10. doi: 10.1038/nm1108
89. Gray JI, Westerhof LM, MacLeod MKL. The roles of resident, central and
effector memory CD4 T-cells in protective immunity following infection or
vaccination. Immunology. (2018) 154:574–81. doi: 10.1111/imm.12929
90. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation
by CD4+CD25+ immunoregulatory cells. J Immunol. (2001) 167:1137–40.
doi: 10.4049/jimmunol.167.3.1137
91. Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: direct
suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol.
(2005) 175:4180–3. doi: 10.4049/jimmunol.175.7.4180
92. Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri, SV. Cutting
edge: human CD4+CD25+ T cells restrain the maturation and antigen-
presenting function of dendritic cells. J Immunol. (2004) 172:4676–80.
doi: 10.4049/jimmunol.172.8.4676
93. Taams LS, van Amelsfort JMR, Tiemessen MM, Jacobs KMG, de Jong
EC, Akbar AN, et al. Modulation of monocyte/macrophage function by
human CD4+CD25+ regulatory T cells. Hum Immunol. (2005) 66:222–30.
doi: 10.1016/j.humimm.2004.12.006
94. Brincks EL, Roberts AD, Cookenham T, Sell S, Kohlmeier JE, Blackman
MA, et al. Antigen-specific memory regulatory CD4+Foxp3+ T cells control
memory responses to influenza virus infection. J Immunol. (2013) 190:3438–
46. doi: 10.4049/jimmunol.1203140
95. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK.
Response to self antigen imprints regulatory memory in tissues. Nature.
(2011) 480:538–42. doi: 10.1038/nature10664
96. Cvetanovich GL, Hafler DA. Human regulatory T cells in
autoimmune diseases. Curr Opin Immunol. (2010) 22:753–60.
doi: 10.1016/j.coi.2010.08.012
97. Kim B-S, Kim I-K, Park Y-J, Kim Y-S, Kim Y-S, Chang W-S, et al.
Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing
Th2-mediated allergic asthma. Proc Natl Acad Sci. (2010) 107:8742–7.
doi: 10.1073/PNAS.0911756107
Frontiers in Immunology | www.frontiersin.org 15 April 2019 | Volume 10 | Article 625
Kieffer et al. Memory T Cells in Pregnancy
98. Hu C-C, JengW-J, Chen Y-C, Fang J-H, Huang C-H, TengW, et al. Memory
regulatory T cells increase only in inflammatory phase of chronic hepatitis B
infection and related to galectin-9/Tim-3 interaction. Sci Rep. (2017) 7:15280.
doi: 10.1038/s41598-017-15527-x
99. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development
by the transcription factor Foxp3. Science. (2003) 299:1057–61.
doi: 10.1126/science.1079490
100. Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois
AE, Van Oosterhout AJ, et al. Preeclampsia is associated with
lower percentages of regulatory T cells in maternal blood.
Hypertens Pregnancy. (2009) 28:300–11. doi: 10.1080/10641950802
601237
101. Winger EE, Reed JL. Low circulating CD4+ CD25+ Foxp3+ T
regulatory cell levels predict miscarriage risk in newly pregnant women
with a history of failure. Am J Reprod Immunol. (2011) 66:320–8.
doi: 10.1111/j.1600-0897.2011.00992.x
102. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is
associated with reduced expression of the T-regulatory cell transcription
factor Foxp3 in endometrial tissue. Mol Hum Reprod. (2006) 12:301–8.
doi: 10.1093/molehr/gal032
103. Wagner MI, Jöst M, Spratte J, Schaier M, Mahnke K, Meuer S, et al.
Differentiation of ICOS+ and ICOS- recent thymic emigrant regulatory T
cells (RTE T regs) during normal pregnancy, pre-eclampsia and HELLP
syndrome. Clin Exp Immunol. (2016) 183:129–42. doi: 10.1111/cei.12693
104. Dong S, Maiella S, Xhaard A, Pang Y, Wenandy L, Larghero J, et al.
Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory
T-cell populations in homeostatic conditions and during graft-versus-host
disease. Blood. (2013) 122:1802–12. doi: 10.1182/BLOOD-2013-02-482539
105. Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive
as long-term memory cells. Eur J Immunol. (2012) 42:1981–8.
doi: 10.1002/eji.201242540
106. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and
regulation of T follicular helper cells. J Exp Med. (2012) 209:1241–53.
doi: 10.1084/jem.20120994
107. He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, et al. Circulating
precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T Cells indicate Tfh cell
activity and promote antibody responses upon antigen reexposure.
Immunity. (2013) 39:770–81. doi: 10.1016/j.immuni.2013.09.007
108. Clark RA. Resident memory T cells in human health and disease. Sci Transl
Med. (2015) 7:269rv1. doi: 10.1126/scitranslmed.3010641
109. Turner DL, Farber DL. Mucosal resident memory CD4T cells in
protection and immunopathology. Front Immunol. (2014) 5:331.
doi: 10.3389/fimmu.2014.00331
110. Long HM, Chagoury OL, Leese AM, Ryan GB, James E, Morton LT, et al.
MHC II tetramers visualize human CD4 + T cell responses to Epstein–
Barr virus infection and demonstrate atypical kinetics of the nuclear antigen
EBNA1 response. J Exp Med. (2013) 210:933–49. doi: 10.1084/jem.20121437
111. Gattinoni L, Speiser DE, Lichterfeld M, Bonini C. T memory stem cells in
health and disease. Nat Med. (2017) 23:18–27. doi: 10.1038/nm.4241
112. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets
of memory T lymphocytes with distinct homing potentials and effector
functions. J Immunol. (2014) 192:840–4. doi: 10.1126/science.1058867
113. Harty JT, Badovinac VP. Shaping and reshaping CD8+ T-cell memory. Nat
Rev Immunol. (2008) 8:107–19. doi: 10.1038/nri2251
114. Chang JT, Wherry EJ, Goldrath AW. Molecular regulation of effector
and memory T cell differentiation. Nat Immunol. (2014) 15:1104–15.
doi: 10.1038/ni.3031
115. Gattinoni L, Zhong X-S, Palmer DC, Ji Y, Hinrichs CS, Yu Z, et al. Wnt
signaling arrests effector T cell differentiation and generates CD8+memory
stem cells. Nat Med. (2009) 15:808–13. doi: 10.1038/nm.1982
116. Shen J, Luo X, Wu Q, Huang J, Xiao G, Wang L, et al. A subset of
CXCR5+CD8+ T cells in the germinal centers from human tonsils and
lymph nodes help B cells produce immunoglobulins. Front Immunol. (2018)
9:2287. doi: 10.3389/fimmu.2018.02287
117. Youngblood B, Hale JS, Kissick HT, Ahn E, Xu X, Wieland A, et al. Effector
CD8T cells dedifferentiate into long-lived memory cells. Nature. (2017)
552:404–9. doi: 10.1038/nature25144
118. Akondy RS, Fitch M, Edupuganti S, Yang S, Kissick HT, Li KW, et al. Origin
and differentiation of human memory CD8T cells after vaccination. Nature.
(2017) 552:362–7. doi: 10.1038/nature24633
119. Ahmed R, Bevan MJ, Reiner SL, Fearon DT. The precursors of
memory: models and controversies. Nat Rev Immunol. (2009) 9:662–8.
doi: 10.1038/nri2619
120. White JT, Cross EW, Kedl RM. Antigen-inexperienced memory CD8+ T
cells: where they come from and why we need them. Nat Rev Immunol.
(2017) 17:391–400. doi: 10.1038/nri.2017.34
121. Appay V, van Lier RAW, Sallusto F, Roederer M. Phenotype and function of
human T lymphocyte subsets: consensus and issues. Cytom. Part A. (2008)
73A:975–83. doi: 10.1002/cyto.a.20643
122. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA.
Seminal fluid induces leukocyte recruitment and cytokine and chemokine
mRNA expression in the human cervix after coitus. J Immunol. (2012)
188:2445–54. doi: 10.4049/jimmunol.1102736
123. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective
expression of the interleukin 7 receptor identifies effector CD8T cells
that give rise to long-lived memory cells. Nat Immunol. (2003) 4:1191–8.
doi: 10.1038/ni1009
124. van Egmond A, van der Keur C, Swings GMJS, Scherjon SA, Claas FHJ. The
possible role of virus-specific CD8+ memory T cells in decidual tissue. J
Reprod Immunol. (2016) 113:1–8. doi: 10.1016/j.jri.2015.09.073
125. Piper KP, McLarnon A, Arrazi J, Horlock C, Ainsworth J, Kilby MD, et al.
Functional HY-specific CD8+ T cells are found in a high proportion of
women following pregnancy with a male fetus. Biol Reprod. (2007) 76:96–
101. doi: 10.1095/biolreprod.106.055426
126. Graef P, Buchholz VR, Stemberger C, Flossdorf M, Henkel L, Schiemann
M, et al. Serial transfer of single-cell-derived immunocompetence reveals
stemness of CD8+central memory T cells. Immunity. (2014) 41:116–26.
doi: 10.1016/j.immuni.2014.05.018
127. Topham DJ, Reilly EC. Tissue-resident memory CD8+ T cells:
from phenotype to function. Front Immunol. (2018) 9:515.
doi: 10.3389/fimmu.2018.00515
128. Watanabe R. Resident memory t cells in mouse and human. Jap J Clin
Immunol. (2016) 39:505–12. doi: 10.2177/jsci.39.505
129. Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in
immune defence.Nat Rev Immunol. (2016) 16:79–89. doi: 10.1038/nri.2015.3
130. Carico E, Atlante M, Giarnieri E, Raffa S, Bucci B, Giovagnoli MR,
et al. E-cadherin and alpha-catenin expression in normal, hyperplastic and
neoplastic endometrium. Anticancer Res. (2010) 30:4993–7.
131. Blechschmidt K, Mylonas I, Mayr D, Schiessl B, Schulze S, Becker K-F, et al.
Expression of E-cadherin and its repressor Snail in placental tissue of normal,
preeclamptic and HELLP pregnancies. Virchows Arch. (2007) 450:195–202.
doi: 10.1007/s00428-006-0343-x
132. Hadley GA, Bartlett ST, Via CS, Rostapshova EA, Moainie S. The epithelial
cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of
alloreactive CD8+ CTL. J Immunol. (1997) 159:3748–56.
133. Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, et al.
Cutting edge: CD69 interference with sphingosine-1-phosphate receptor
function regulates peripheral T cell retention. J Immunol. (2015) 194:2059–
63. doi: 10.4049/JIMMUNOL.1402256
134. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon M-L, et al.
The developmental pathway for CD103+CD8+ tissue-resident memory T
cells of skin. Nat Immunol. (2013) 14:1294–301. doi: 10.1038/ni.2744
135. Machicote A, Belén S, Baz P, Billordo LA, Fainboim L. Human CD8+HLA-
DR+ regulatory T cells, similarly to classical CD4+Foxp3+ cells, suppress
immune responses via PD-1/PD-L1 Axis. Front Immunol. (2018) 9:2788.
doi: 10.3389/fimmu.2018.02788
136. Rifa’i M, Kawamoto Y, Nakashima I, Suzuki H. Essential roles of
CD8+ CD122+ regulatory T cells in the maintenance of T cell
homeostasis. J Exp Med. (2004) 200:1123–34. doi: 10.1084/jem.200
40395
137. Arruvito L, Payaslián F, Baz P, Podhorzer A, Billordo A, Pandolfi J,
et al. Identification and clinical relevance of naturally occurring human
CD8+HLA-DR+ regulatory T cells. J Immunol. (2014) 193:4469–76.
doi: 10.4049/jimmunol.1401490
Frontiers in Immunology | www.frontiersin.org 16 April 2019 | Volume 10 | Article 625
Kieffer et al. Memory T Cells in Pregnancy
138. Quigley MF, Gonzalez VD, Granath A, Andersson J, Sandberg JK. CXCR5+
CCR7– CD8T cells are early effector memory cells that infiltrate tonsil
B cell follicles. Eur J Immunol. (2007) 37:3352–62. doi: 10.1002/eji.2006
36746
139. Sabatino M, Hu J, Sommariva M, Gautam S, Fellowes V, Hocker JD, et al.
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory
stem cells for the treatment of human B-cell malignancies. Blood. (2016)
128:519–28. doi: 10.1182/blood-2015-11-683847
140. Guan L, Li X, Wei J, Liang Z, Yang J, Weng X, et al. Antigen-specific CD8+
memory stem T cells generated from human peripheral blood effectively
eradicate allogeneic targets in mice. Stem Cell Res Ther. (2018) 9:337.
doi: 10.1186/s13287-018-1080-1
141. Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building
the ultimate antitumour T cell. Nat Rev Cancer. (2012) 12:671–84.
doi: 10.1038/nrc3322
142. Robillard PY, Hulsey TC, Périanin J, Janky E, Miri EH,
Papiernik E. Association of pregnancy-induced hypertension
with duration of sexual cohabitation before conception. Lancet.
(1994) 344:973–5.
143. Saftlas AF, Rubenstein L, Prater K, Harland KK, Field E, Triche EW.
Cumulative exposure to paternal seminal fluid prior to conception and
subsequent risk of preeclampsia. J Reprod Immunol. (2014) 101–102:104–10.
doi: 10.1016/j.jri.2013.07.006
144. Koelman CA, Coumans AB, Nijman HW, Doxiadis II, Dekker GA, Claas
FH. Correlation between oral sex and a low incidence of preeclampsia: a
role for soluble HLA in seminal fluid? J Reprod Immunol. (2000) 46:155–66.
doi: 10.1016/S0165-0378(99)00062-5
145. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent
miscarriage. Cochrane Database Syst Rev. (2014) 1:CD000112.
doi: 10.1002/14651858.CD000112.pub3
146. Crawford G, Ray A, Gudi A, Shah A, Homburg R. The role of seminal
plasma for improved outcomes during in vitro fertilization treatment: review
of the literature and meta-analysis. Hum Reprod Update. (2015) 21:275–84.
doi: 10.1093/humupd/dmu052
147. Shin H, Iwasaki A. A vaccine strategy that protects against genital
herpes by establishing local memory T cells. Nature. (2012) 491:463–7.
doi: 10.1038/nature11522
148. Homann D, Teyton L, Oldstone MBA. Differential regulation of
antiviral T-cell immunity results in stable CD8+ but declining
CD4+ T-cell memory. Nat Med. (2001) 7:913–9. doi: 10.1038/
90950
149. Nelson RW, McLachlan JB, Kurtz JR, Jenkins MK. CD4+ T Cell
persistence and function after infection are maintained by low-level
peptide: MHC class II presentation. J Immunol. (2013) 190:2828–34.
doi: 10.4049/jimmunol.1202183
150. Kinder JM, Jiang TT, Clark DR, Chaturvedi V, Xin L, Ertelt JM, et al.
Pregnancy-induced maternal regulatory T cells, bona fide memory or
maintenance by antigenic reminder from fetal cell microchimerism?
Chimerism. (2014) 5:16–9. doi: 10.4161/chim.28241
151. Kinder JM, Jiang TT, Ertelt JM, Xin L, Strong BS, Shaaban AF, et al.
Cross-generational reproductive fitness enforced by microchimeric
maternal cells. Cell. (2015) 162:505–15. doi: 10.1016/j.cell.2015.
07.006
152. Kinder JM, Stelzer IA, Arck PC, Way SS. Immunological implications of
pregnancy-induced microchimerism. Nat Rev Immunol. (2017) 17:483–94.
doi: 10.1038/nri.2017.38
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Kieffer, Laskewitz, Scherjon, Faas and Prins. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 17 April 2019 | Volume 10 | Article 625
